Mounjaro and Pregnancy UK: Safety Guide | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Mounjaro and Pregnancy - Cheapest UK Price £124.99

Get the cheapest UK price on Mounjaro from £124.99 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £124.99 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Mounjaro and Pregnancy UK: What You Need to Know

If you're researching mounjaro and pregnancy uk guidance, you're taking an important step in planning your health journey. Mounjaro (tirzepatide) is not recommended during pregnancy or whilst breastfeeding, and UK prescribers advise stopping treatment at least two months before attempting conception. At Cured Pharmacy, our UK-registered clinical team provides personalised guidance on safely managing weight loss medications around family planning.

Is Mounjaro Safe During Pregnancy?

Mounjaro is contraindicated during pregnancy in the UK. The MHRA licensing does not permit tirzepatide use in pregnant women due to insufficient human safety data and evidence of adverse developmental effects observed in animal reproduction studies [1]. If you become pregnant whilst taking Mounjaro, you should stop treatment immediately and contact your prescriber or GP.

Animal studies showed tirzepatide crossed the placental barrier and was associated with reduced foetal growth and skeletal malformations at exposures relevant to human dosing [1]. Whilst animal data cannot be directly extrapolated to humans, the precautionary principle applies — no GLP-1 receptor agonist, including tirzepatide, is considered safe during pregnancy in UK clinical practice.

Weight loss itself during pregnancy is not recommended, as adequate maternal nutrition is essential for foetal development. If you're planning a pregnancy or discover you're pregnant whilst on Mounjaro, your UK prescriber will discuss appropriate next steps and alternative management strategies for your health.

When to Stop Mounjaro Before Trying to Conceive

UK prescribers typically recommend discontinuing Mounjaro at least two months before attempting conception. This washout period allows tirzepatide to clear your system completely, as the medication has a half-life of approximately five days, meaning it takes around 25 days for elimination after your final dose [2].

The two-month guidance provides an additional safety margin beyond pharmacokinetic elimination. This timeframe also allows your menstrual cycle to normalise if it was affected by weight changes, and gives you time to establish stable eating patterns without medication support before pregnancy.

Planning Your Conception Timeline

Discuss your family planning intentions with your UK prescriber before starting Mounjaro, or as soon as you begin considering pregnancy. Your prescriber can help you plan a safe discontinuation schedule, optimise your weight beforehand to support a healthy pregnancy, and ensure any other medications you're taking are pregnancy-compatible. Women of childbearing potential should use reliable contraception throughout Mounjaro treatment and for two months after stopping.

Mounjaro and Breastfeeding: Current UK Guidance

Mounjaro is not recommended during breastfeeding in the UK. It is unknown whether tirzepatide passes into human breast milk, though animal studies demonstrated excretion in milk [1]. Given the potential for serious adverse reactions in nursing infants and the lack of human safety data, UK prescribers advise against using Mounjaro whilst breastfeeding.

If you're breastfeeding and considering weight loss treatment, discuss safer alternatives with your UK prescriber. Dietary modification and gradual exercise programmes are typically recommended as first-line approaches postpartum. Prescription weight loss medications are generally deferred until after you've finished breastfeeding, allowing you to focus on nourishing both yourself and your baby without medication-related concerns.

Treatment Active Ingredient Washout Before Conception Starting Price
Mounjaro Tirzepatide 2 months minimum From £124.99
Wegovy Semaglutide 2 months minimum From £69.00
Saxenda Liraglutide 1 month minimum From £68.00
Orlistat Orlistat Not systemically absorbed* From £32.00

How Mounjaro May Affect Fertility

Weight loss achieved with Mounjaro may actually improve fertility in women with obesity-related reproductive challenges. Excess body weight is associated with polycystic ovary syndrome (PCOS), anovulation, and reduced conception rates [3]. Clinical trials showed significant weight reduction with tirzepatide — averaging 15-22.5% body weight loss depending on dose — which can restore ovulatory cycles in some women [2].

However, this fertility improvement creates an important consideration: if you're not planning pregnancy, ensure you're using effective contraception whilst on Mounjaro. Some women experience unexpected conception after significant weight loss normalises their hormonal balance. The medication itself has not been shown to directly impair fertility, but as discussed, it must be stopped well before attempting conception.

What Happens If You Get Pregnant on Mounjaro?

If you discover you're pregnant whilst taking Mounjaro, stop the medication immediately and contact your prescriber or GP for guidance. Early cessation minimises potential foetal exposure, particularly during the critical first trimester when organ development occurs.

Your healthcare provider will arrange appropriate antenatal care and monitoring. Most women who inadvertently conceive on weight loss medications go on to have healthy pregnancies, but early medical review ensures any additional monitoring or interventions are arranged if needed. Be transparent about your medication history with your antenatal team so they can provide informed care throughout your pregnancy.

Reporting Pregnancy Exposure

UK prescribers may report pregnancy exposures to tirzepatide to the MHRA Yellow Card scheme. This pharmacovigilance helps build real-world safety data and informs future clinical guidance. Your participation in this reporting, whilst voluntary, contributes valuable information that protects other women in similar situations.

Alternative Weight Loss Options for Women Planning Pregnancy

If you're planning pregnancy within the next six months but want to optimise your weight beforehand, discuss the timeline carefully with your UK prescriber. For longer planning horizons (12+ months), Mounjaro or other GLP-1 treatments may still be appropriate with proper discontinuation scheduling. For shorter timeframes, non-pharmacological approaches are typically recommended.

Lifestyle interventions including structured dietary programmes, behavioural support, and supervised exercise can achieve meaningful weight loss without medication-related pregnancy concerns. If prescription treatment is needed and pregnancy is planned soon, your prescriber might consider medications with shorter half-lives or different safety profiles, though all weight loss medications require careful evaluation in this context. At Cured Pharmacy, our UK clinical team provides personalised consultations considering your individual health goals, timeline, and medical history to recommend the most appropriate approach.

Postpartum Weight Management

Many women consider weight loss medications after completing their family or between pregnancies. Mounjaro can be safely initiated postpartum once you've finished breastfeeding and received medical clearance. Your prescriber will assess your overall health, ensure any pregnancy-related conditions have resolved, and confirm appropriate timing before starting treatment. This approach allows you to achieve your weight goals whilst prioritising your baby's nutritional needs during the breastfeeding period.

Scientific References

  1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298
  2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  3. Silvestris, E., et al. (2018). Obesity as disruptor of the female fertility. Reproductive Biology and Endocrinology, 16(1), 22. https://doi.org/10.1186/s12958-018-0336-z

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication, particularly when planning pregnancy or breastfeeding.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can you take Mounjaro while pregnant?
No, Mounjaro is contraindicated during pregnancy in the UK. If you become pregnant whilst taking tirzepatide, stop the medication immediately and contact your prescriber or GP for guidance.
How long after stopping Mounjaro can I get pregnant?
UK prescribers recommend waiting at least two months after your final Mounjaro dose before attempting conception. This allows complete medication clearance and provides an appropriate safety margin.
Does Mounjaro affect fertility?
Mounjaro does not directly impair fertility. In fact, the weight loss it produces may improve fertility in women with obesity-related reproductive challenges, so use reliable contraception if you're not planning pregnancy.
Can I breastfeed while taking Mounjaro?
No, Mounjaro is not recommended during breastfeeding in the UK. It is unknown whether tirzepatide passes into human breast milk, and the potential risks to nursing infants have not been adequately studied.
What if I didn't know I was pregnant on Mounjaro?
Stop the medication immediately and contact your healthcare provider. Most women who inadvertently conceive on weight loss medications have healthy pregnancies, but early medical review ensures appropriate monitoring.
Are there safer weight loss options if I'm planning pregnancy soon?
If pregnancy is planned within six months, non-pharmacological approaches are typically recommended. Discuss your timeline with a UK prescriber who can recommend appropriate dietary, behavioural, and exercise interventions.
Can Mounjaro cause birth defects?
Animal studies showed adverse developmental effects with tirzepatide, but human data are insufficient. As a precaution, Mounjaro is not used during pregnancy in the UK, and a two-month washout before conception is advised.
When can I start Mounjaro after giving birth?
You can start Mounjaro after finishing breastfeeding and receiving medical clearance from your UK prescriber. This ensures your postpartum recovery is complete and your baby's nutritional needs are met first.
Should I stop taking Mounjaro if I'm planning to get pregnant in the UK?
Yes, UK guidance recommends stopping Mounjaro at least two months before trying to conceive due to potential risks. Cured Pharmacy prescribers can provide tailored advice on safely discontinuing treatment and discuss alternative weight management options during your pregnancy planning.
What does UK guidance say about Mounjaro and pregnancy risks?
UK guidance states Mounjaro should not be used during pregnancy as animal studies have shown potential harm to the developing baby. If you discover you're pregnant while taking Mounjaro, stop immediately and contact your healthcare provider or Cured Pharmacy for urgent advice.
Can I breastfeed while using Mounjaro according to UK guidelines?
UK guidance advises against using Mounjaro while breastfeeding as it's unknown whether tirzepatide passes into breast milk. Cured Pharmacy can help you discuss safe alternatives for weight management during breastfeeding or plan when to resume Mounjaro after you've finished nursing.
Where can I get the cheapest Mounjaro price in the UK with pregnancy advice?
Cured Pharmacy offers Mounjaro from £124.99 with £20 off using code Weightlossnew, plus expert pregnancy and family planning guidance from UK-registered prescribers. Our team provides comprehensive consultations covering safe use, contraception requirements, and stopping protocols for pregnancy planning.
Do I need to use contraception while taking Mounjaro in the UK?
Yes, UK guidance strongly recommends using effective contraception during Mounjaro treatment and for two months after stopping due to pregnancy risks. Cured Pharmacy prescribers will discuss appropriate contraception options during your consultation to ensure safe use of tirzepatide while preventing unplanned pregnancy.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 17 July 2026